Teva Pharmaceuticals – A Deal Too Far?
Teva Pharmaceuticals (TEVA) is officially in crisis mode. Just a year after it completed the purchase of Allergan’s (NYSE:AGN) generics business, Teva is under real financial pressure. As the narrative is clearly negative and could continue to remain …
and more >>
Source: pharmaceutical – Google News
Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd